Log in to save to my catalogue

Intralymphatic immunotherapy

Intralymphatic immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eb4f740105ea4bb2acfc719782d4cf0b

Intralymphatic immunotherapy

About this item

Full title

Intralymphatic immunotherapy

Publisher

United States: BioMed Central Ltd

Journal title

The World Allergy Organization journal, 2015-03, Vol.8 (1), p.9-9, Article 9

Language

English

Formats

Publication information

Publisher

United States: BioMed Central Ltd

More information

Scope and Contents

Contents

Gold Standard allergen-specific immunotherapy is associated with low efficacy because it requires either many subcutaneous injections of allergen or even more numerous sublingual allergen administrations to achieve amelioration of symptoms. Intralymphatic vaccination can maximize immunogenicity and hence efficacy. We and others have demonstrated th...

Alternative Titles

Full title

Intralymphatic immunotherapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_eb4f740105ea4bb2acfc719782d4cf0b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eb4f740105ea4bb2acfc719782d4cf0b

Other Identifiers

ISSN

1939-4551

E-ISSN

1939-4551

DOI

10.1186/s40413-014-0047-7

How to access this item